Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Behrens

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|June 18, 2010
[Immunology 2010]G M Behrens, R E Schmidt
MMW Fortschritte Der Medizin|June 23, 2000
[Lipodystrophy and metabolic disorders in anti-HIV therapy]G M Behrens, M Stoll, R E Schmidt
Lancet (London, England)|May 30, 2001
Pulmonary hypersensitivity reaction induced by efavirenzG M Behrens, M Stoll, R E Schmidt
Drug Safety|July 29, 2000
Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?G M Behrens, M Stoll, R E Schmidt
Deutsche Medizinische Wochenschrift (1946)|September 14, 2001
[Immune reconstitution syndrome. A new disease in HIV-infected patients effectively treated with antiretroviral drugs]M Stoll, G M Behrens, R E Schmidt
Immunobiology|September 19, 2000
Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapyG M Behrens, D Meyer, M Stoll, et al.
AIDS (London, England)|September 14, 2000
Lessons from lipodystrophy: LMNA, encoding lamin A/C, in HIV therapy-associated lipodystrophyG M Behrens, D Lloyd, H H Schmidt, et al.
The Open AIDS Journal|June 7, 2011
A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN TrialK U Ulbricht, G M Behrens, M Stoll, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|June 18, 2010
[Immunology 2010]G M Behrens, R E Schmidt
MMW Fortschritte Der Medizin|June 23, 2000
[Lipodystrophy and metabolic disorders in anti-HIV therapy]G M Behrens, M Stoll, R E Schmidt
Lancet (London, England)|May 30, 2001
Pulmonary hypersensitivity reaction induced by efavirenzG M Behrens, M Stoll, R E Schmidt
Drug Safety|July 29, 2000
Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?G M Behrens, M Stoll, R E Schmidt
Deutsche Medizinische Wochenschrift (1946)|September 14, 2001
[Immune reconstitution syndrome. A new disease in HIV-infected patients effectively treated with antiretroviral drugs]M Stoll, G M Behrens, R E Schmidt
Immunobiology|September 19, 2000
Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapyG M Behrens, D Meyer, M Stoll, et al.
AIDS (London, England)|September 14, 2000
Lessons from lipodystrophy: LMNA, encoding lamin A/C, in HIV therapy-associated lipodystrophyG M Behrens, D Lloyd, H H Schmidt, et al.
The Open AIDS Journal|June 7, 2011
A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN TrialK U Ulbricht, G M Behrens, M Stoll, et al.
Pageof 1